12.34
+0.19
(1.56%)
Real-time:
10:06AM EDT
NYSEMKT
real-time data -
Disclaimer
Currency in USD
| Range | 12.15 - 12.42 |
| 52 week | 3.72 - 12.57 |
| Open | 12.15 |
| Vol / Avg. | 1,694.00/139,439.00 |
| Mkt cap | 353.96M |
| P/E | 31.69 |
| Div/yield | - |
| EPS | 0.39 |
| Shares | 28.68M |
| Beta | 0.53 |
| Inst. own | 27% |
Events
May 8, 2013
Q3 2013 Lannett Company Inc Earnings Conference Call
May 6, 2013
Q3 2013 Lannett Company Inc Earnings Release
May 1, 2013
Lannett Company Inc at Needham Healthcare Conference
Mar 18, 2013
Lannett Company Inc at Roth Conference
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | 10.16% | 3.27% |
| Operating margin | 12.03% | 5.62% |
| EBITD margin | - | 10.28% |
| Return on average assets | 9.39% | 2.63% |
| Return on average equity | 13.11% | 3.64% |
| Employees | 324 | - |
| Carbon Disclosure Rating | - | - |
Address
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Lannett Company, Inc. is engaged in developing, manufacturing, marketing and distributing generic versions of branded pharmaceutical products. All of the Company�s products manufactured and/or sold are prescription products. The Company�s products containing Levo are produced and marketed with 12 varying potencies. In addition to generic Levo tablets, the Company also markets and distributes Unithroid tablets, a branded version of Levo, which is produced and marketed with 11 varying potencies. The Company�s Levo tablets are used to treat hypothyroidism and other thyroid disorders. The Company�s generic Levo tablets and Unithroid tablets are manufactured by Jerome Stevens Pharmaceuticals (JSP). As of June 30, 2012, the Company manufactured and/or distributed 30 products.
Officers and directors
| Jeffrey Farber | Chairman of the Board | |
| Arthur P. Bedrosian J.D. | President, Chief Executive Officer, Director | |
| Ronald A. West | Vice Chairman of the Board, Lead Independent Director | |
| Martin P. Galvan CPA | Chief Financial Officer, Vice President - Finance, Treasurer | |
| William F. Schreck | Chief Operating Officer | |
| Robert Ehlinger | Vice President - Logistics, Chief Information Officer | |
| Ernest J. Sabo | Vice President - Regulatory Affairs, Chief Compliance Officer | |
| Kevin R. Smith | Vice President - Sales and Marketing | |
| William R. Farber Ph.D. | Chairman Emeritus | |
| David Drabik | Independent Director |